Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nexell's Baxter deal leaves it without future

This article was originally published in Clinica

Executive Summary

Lengthy and unsuccessful efforts to raise capital was one of the key reasons behind Nexell's decision last week to opt for closure. Staff posts will be cut to just three while the Irvine, California company progresses with an orderly wind down. Efforts to merge the company with a third party also proved fruitless. Finally, Nexell opted for the chosen course in order to preserve its assets and meet its obligations, said president and CEO William Albright.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066600

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel